1![766 IEEE TRANSACTIONS ON MEDICAL IMAGING, VOL. 31, NO. 3, MARCH 2012 Automatic Assessment of Macular Edema From Color Retinal Images 766 IEEE TRANSACTIONS ON MEDICAL IMAGING, VOL. 31, NO. 3, MARCH 2012 Automatic Assessment of Macular Edema From Color Retinal Images](https://www.pdfsearch.io/img/c4a1f051c33ba6b6765c90260af25de8.jpg) | Add to Reading ListSource URL: cvit.iiit.ac.inLanguage: English - Date: 2015-07-10 15:16:59
|
---|
2![Micropulse laser for macular edema p r i n c i p l e s , n e w pa r a m e t e r s a n d r e s u lt s w i t h 577 n m Frédéric Hamon MD 1 Micropulse laser for macular edema p r i n c i p l e s , n e w pa r a m e t e r s a n d r e s u lt s w i t h 577 n m Frédéric Hamon MD 1](https://www.pdfsearch.io/img/06f821292744a8b4938fd81a2495ff76.jpg) | Add to Reading ListSource URL: www.quantel-medical.comLanguage: English - Date: 2015-08-11 03:06:16
|
---|
3![Current Eye Research 2001, Vol. 22, No. 2, pp. 140–$16.00 © Swets & Zeitlinger Current Eye Research 2001, Vol. 22, No. 2, pp. 140–$16.00 © Swets & Zeitlinger](https://www.pdfsearch.io/img/41af22024ad290bf51f8a1665de5c33a.jpg) | Add to Reading ListSource URL: www.scleracorp.comLanguage: English - Date: 2013-08-13 00:02:52
|
---|
4![September 16, 2014 EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by yea September 16, 2014 EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by yea](https://www.pdfsearch.io/img/0921ad3316ca7af5aea0831fcd50f7d0.jpg) | Add to Reading ListSource URL: files.shareholder.comLanguage: English |
---|
5![MACULART meeting PARISFIRST ANNOUNCEMENTJUNE 2015 MACULART meeting PARISFIRST ANNOUNCEMENTJUNE 2015](https://www.pdfsearch.io/img/adb5cad41968c389c978a6ff0bceb518.jpg) | Add to Reading ListSource URL: www.symposiacongressi.euLanguage: English - Date: 2015-01-13 10:48:00
|
---|
6![Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca](https://www.pdfsearch.io/img/eb59f20a3c34192fd24c90fa220a0b00.jpg) | Add to Reading ListSource URL: www.novartis.caLanguage: English - Date: 2015-05-13 10:22:10
|
---|
7![FOR IMMEDIATE RELEASE Aerpio Therapeutics to Present at Needham Healthcare Conference Cincinnati, OH, April 7, 2013 – Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovativ FOR IMMEDIATE RELEASE Aerpio Therapeutics to Present at Needham Healthcare Conference Cincinnati, OH, April 7, 2013 – Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovativ](https://www.pdfsearch.io/img/810e260fa13cc8ceea8ac656f7b6afae.jpg) | Add to Reading ListSource URL: www.aerpio.comLanguage: English - Date: 2014-04-10 11:19:28
|
---|
8![COMUNICADO DE PRENSA Alcon y la Federación de Diabéticos Españoles colaboran en la concienciación sobre la prevención del Edema Macular • COMUNICADO DE PRENSA Alcon y la Federación de Diabéticos Españoles colaboran en la concienciación sobre la prevención del Edema Macular •](https://www.pdfsearch.io/img/67a2cde725adfb6fb3cfd744344a7736.jpg) | Add to Reading ListSource URL: www.alcon.esLanguage: Spanish - Date: 2014-02-06 14:24:46
|
---|
9![FOR IMMEDIATE RELEASE Aerpio Therapeutics Initiates Phase 2 Study of Tie2 Activator AKB-9778 for the Treatment of Diabetic Macular Edema Cincinnati, OH, February 13, 2014 – Aerpio Therapeutics, Inc., a clinical-stage b FOR IMMEDIATE RELEASE Aerpio Therapeutics Initiates Phase 2 Study of Tie2 Activator AKB-9778 for the Treatment of Diabetic Macular Edema Cincinnati, OH, February 13, 2014 – Aerpio Therapeutics, Inc., a clinical-stage b](https://www.pdfsearch.io/img/6582c8d6e983948fb53c3972dab2f653.jpg) | Add to Reading ListSource URL: www.aerpio.comLanguage: English - Date: 2014-02-13 16:12:56
|
---|
10![FOR IMMEDIATE RELEASE Aerpio Therapeutics Closes $22M Financing --Proceeds Support Expanded Development Program for AKB-9778 and Advancement of HIF1 Activator into the Clinic-Cincinnati, OH, April 23, 2014 – Aerpio The FOR IMMEDIATE RELEASE Aerpio Therapeutics Closes $22M Financing --Proceeds Support Expanded Development Program for AKB-9778 and Advancement of HIF1 Activator into the Clinic-Cincinnati, OH, April 23, 2014 – Aerpio The](https://www.pdfsearch.io/img/c8678aa71fdb0a0eb7776ee59bf2f958.jpg) | Add to Reading ListSource URL: www.aerpio.comLanguage: English - Date: 2014-04-23 10:17:58
|
---|